| |
Genotype
|
N
|
BPD score ± STD
|
F
|
df
|
p
|
η2
|
power
|
|---|
|
COMT
|
Met/Met
|
34
|
4.79 ± 2.54
|
0.367
|
2,131
|
0.694
|
0.006
|
0.108
|
| |
Met/Val
|
70
|
4.71 ± 2.29
| | | | | |
| |
Val/Val
|
32
|
5.16 ± 2.57
| | | | | |
|
DAT1
|
9/9
|
11
|
4.64 ± 2.87
|
0.120
|
2,131
|
0.887
|
0.002
|
0.068
|
|
40 bp
|
9/10
|
48
|
4.75 ± 2.74
|
0.082
|
1,132
|
0.775
|
0.001
|
0.059
|
|
VNTR
|
10/10*
|
77
|
4.92 ± 2.13
| | | | | |
|
DRD2
|
B1/B1
|
3
|
3.33 ± 3.22
|
1.712
|
2,131
|
0.184
|
0.025
|
0.355
|
|
TaqIB
|
B1/B2
|
37
|
5.38 ± 2.31
|
1.518
|
1,132
|
0.220
|
0.011
|
0.231
|
| |
B2/B2
|
96
|
4.68 ± 2.40
| | | | | |
|
TaqID
|
C/C
|
27
|
4.30 ± 2.54
|
1.490
|
2,131
|
0.229
|
0.022
|
0.313
|
| |
C/T
|
59
|
5.31 ± 2.28
| | | | | |
| |
T/T
|
50
|
4.58 ± 2.43
| | | | | |
|
TaqIA
|
A1/A1
|
4
|
3.75 ± 2.75
|
0.460
|
2,131
|
0.632
|
0.007
|
0.124
|
| |
A1/A2
|
41
|
4.90 ± 2.56
|
0.001
|
1,132
|
0.970
|
0
|
0.050
|
| |
A2/A2
|
91
|
4.86 ± 2.34
| | | | | |
|
DRD4
|
1/1
|
4
|
3.25 ± 2.06
|
1.611
|
2,131
|
0.204
|
0.024
|
0.336
|
|
120 bp
|
1/2
|
40
|
5.18 ± 2.18
|
1.604
|
1,132
|
0.208
|
0.012
|
0.242
|
|
dup
|
2/2
|
92
|
4.76 ± 2.50
| | | | | |
|
-616
|
C/C
|
44
|
5.48 ± 2.45
|
5.146
|
2,131
|
0.007
|
0.073
|
0.818
|
| |
C/G
|
56
|
4.80 ± 2.36
|
8.152
|
1,132
|
0.005
|
0.058
|
0.809
|
| |
G/G
|
36
|
4.11 ± 2.27
| | | | | |
|
-521
|
C/C
|
34
|
5.00 ± 2.54
|
0.463
|
2,131
|
0.630
|
0.007
|
0.124
|
| |
C/T
|
65
|
4.62 ± 2.38
|
0.354
|
1,132
|
0.553
|
0.003
|
0.091
|
| |
T/T
|
37
|
5.08 ± 2.37
| | | | | |
|
48 bp
|
7/7
|
3
|
5.67 ± 1.53
|
0.282
|
2,131
|
0.754
|
0.004
|
0.094
|
|
VNTR
|
one 7
|
35
|
4.77 ± 2.38
|
0.134
|
1,132
|
0.715
|
0.001
|
0.065
|
| |
no 7
|
98
|
4.84 ± 2.45
| | | | | |
|
Haplotype
|
0
|
68
|
4.40 ± 2.34
|
3.602
|
2,131
|
0.030
|
0.052
|
0.658
|
|
-616 C ~
|
1
|
50
|
5.14 ± 2.46
|
6.969
|
1,132
|
0.009
|
0.050
|
0.746
|
|
-521 T
|
2
|
18
|
5.67 ± 2.30
| | | | | |
- The mean ± SD of the sum of borderline symptoms (BPD score) from the self-report SCID-II Screen questionnaire are presented for the different genotype groups. Where it is indicated, in the second set of univariate ANOVAs rare homozygote genotypes (n < 5) or literature-based genotypes were grouped together with the heterozygotes for the fixed factor; sex and age were used as covariates.
- * At the DAT1 VNTR one 10/11 and one 10/12 sample were grouped together with the 10/10 (9-allele absent) genotype group.
